Time for a breather
As at last week, the FSSTI has retraced 38% of its decline from 3905 to Oct
08’s low of 1477. The 38% retracement is the 2400 level. While the index breached the level on an intra-day basis, it had not closed above that level.
The 38% retracement is the most significant resistance level since the index's decline from 3905 and the least we expect is a 5% correction from the recent peak of 2424. The price oscillator index shows the index at an extremely overbought level. Based on that alone, we would advice readers to reduce beta plays and switch to defensive stocks. We had previously labelled the rebound off 2194 as a wave v of 3. We are still of the same view and expect profit taking to set in the coming week. Incidentally, the Hang Seng Index is also at a critical 38% retracement level and price action on that index will have a significant bearing on the FSSTI.
Most of the stocks that we recommended in mid-May, such as City Dev, Wing Tai, SGX, Yangzejiang and Straits Asia Resources had reached our target prices. Expect a pullback in these stocks along with the index.
FSSTI and HSI at 38% Retracement Levels

Source: NextView
We have based this document on information obtained from sources we believe to be reliable, but we do not make any representation
or warranty nor accept any responsibility or liability as to its accuracy, completeness or correctness. Expressions of opinion contained
herein are those of UOB Kay Hian Research Pte Ltd only and are subject to change without notice. Any recommendation contained in
this document does not have regard to the specific investment objectives, financial situation and the particular needs of any specific
addressee. This document is for the information of the addressee only and is not to be taken as substitution for the exercise of judgement
by the addressee. This document is not and should not be construed as an offer or a solicitation of an offer to purchase or subscribe or
sell any securities. UOB Kay Hian and its affiliates, their Directors, officers and/or employees may own or have positions in any
securities mentioned herein or any securities related thereto and may from time to time add to or dispose of any such securities. UOB
Kay Hian and its affiliates may act as market maker or have assumed an underwriting position in the securities of companies discussed
herein (or investments related thereto) and may sell them to or buy them from customers on a principal basis and may also perform or
seek to perform investment banking or underwriting services for or relating to those companies.
UOB Kay Hian (U.K.) Limited, a UOB Kay Hian subsidiary which distributes UOB Kay Hian research for only institutional clients,
is an authorised person in the meaning of the Financial Services and Markets Act 2000 and is regulated by The Securities and Futures
Authority.
In the United States of America, this research report is being distributed by UOB Kay Hian (U.S.) Inc (“UOBKHUS”) which accepts
responsibility for the contents. UOBKHUS is a broker-dealer registered with the U.S. Securities and Exchange Commission and is an
affiliate company of UOBKH. Any U.S. person receiving this report who wishes to effect transactions in any securities referred to herein
should contact UOBKHUS, not its affiliate. The information herein has been obtained from, and any opinions herein are based upon
sources believed reliable, but we do not represent that it is accurate or complete and it should not be relied upon as such. All opinions
and estimates herein reflect our judgement on the date of this report and are subject to change without notice. This report is not intended
to be an offer, or the solicitation of any offer, to buy or sell the securities referred to herein. From time to time, the firm preparing this
report or its affiliates or the principals or employees of such firm or its affiliates may have a position in the securities referred to herein
or hold options, warrants or rights with respect thereto or other securities of such issuers and may make a market or otherwise act as
principal In transactions in any of these securities. Any such non-U.S. persons may have purchased securities referred to herein for their
own account in advance of release of this report. Further information on the securities referred to herein may be obtained from
UOBKHUS upon request.
http://research.uobkayhian.com
|